Paid Clinical Trials Hialeah

Discover 1,216 paid clinical trials in Hialeah, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,216

LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Recruiting

PHASE3

Sponsor:

Intra-Cellular Therapies, Inc.

Location:

Hialeah FL, Miami Springs FL, Miami Lakes FL, Miami Gardens FLshow 38 more

Code:

NCT06372964

Conditions

Bipolar Depression

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

Lumateperone

Placebo

MK-1167A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)

Recruiting

PHASE2

Sponsor:

Merck Sharp & Dohme LLC

Location:

Hialeah FL, Miami FL, Delray Beach FL, Atlantis FLshow 27 more

Code:

NCT06721156

Conditions

Alzheimer Disease

Dementia

Eligibility Criteria

Sex: All

Age: 55 - 70+

Healthy Volunteers: Not accepted

Interventions

MK-1167

Placebo

Bezuclastinib(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Recruiting

PHASE2

Sponsor:

Cogent Biosciences, Inc.

Location:

Hialeah FL, Charleston SC, Atlanta GA, Birmingham ALshow 12 more

Code:

NCT04996875

Conditions

Advanced Systemic Mastocytosis (AdvSM)

SM With an Associated Hematologic Neoplasm (SM-AHN)

Mast Cell Leukemia (MCL)

Aggressive Systemic Mastocytosis (ASM)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

bezuclastinib

Obicetrapib & EzetimibeA CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque

Recruiting

PHASE3

Sponsor:

NewAmsterdam Pharma

Location:

Hialeah FL

Code:

NCT06305559

Conditions

Lipidemia

Coronary Artery Disease

Plaque, Atherosclerotic

Eligibility Criteria

Sex: All

Age: 45+

Healthy Volunteers: Not accepted

Interventions

obicetrapib 10 mg + ezetimibe 10 mg FDC daily

Placebo

SUBLOCADESUBLOCADE Long-term Outcomes

Recruiting

Sponsor:

Indivior Inc.

Location:

Hialeah FL, Miami FL, Hollywood FL, Palmetto Bay FLshow 40 more

Code:

NCT05860959

Conditions

Opioid Use Disorder

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Albuvirtide & 3BNC117Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects

Recruiting

PHASE2

Sponsor:

Frontier Biotechnologies Inc.

Location:

Hialeah FL, Fort Pierce FL, Orlando FL, Atlanta GAshow 3 more

Code:

NCT03719664

Conditions

HIV-1-infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Albuvirtide

3BNC117

Baseline ART

SonelokimabStudy to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared with Placebo in Adult Participants with Moderate to Severe Hidradenitis Suppurativa

Recruiting

PHASE3

Sponsor:

MoonLake Immunotherapeutics AG

Location:

Hialeah FL, Miami FL, Aventura FL, Tampa FLshow 32 more

Code:

NCT06411379

Conditions

Hidradenitis Suppurativa

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sonelokimab

Placebo

Peanut SLITPeanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting

PHASE1

PHASE2

Sponsor:

ALK-Abelló A/S

Location:

Hialeah FL, Tampa FL, Atlanta GA, Chapel Hill NCshow 29 more

Code:

NCT05440643

Conditions

Peanut Allergy

Eligibility Criteria

Sex: All

Age: 4 - 65

Healthy Volunteers: Not accepted

Interventions

Peanut SLIT-tablet

Placebo

VNX001Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

Recruiting

PHASE2

Sponsor:

Vaneltix Pharma, Inc.

Location:

Hialeah FL, Tampa FL, Cartersville GA, Metairie LAshow 7 more

Code:

NCT05737121

Conditions

Interstitial Cystitis

Bladder Pain Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

VNX001

Placebo

Lidocaine

Heparin

Tirzepatide & IxekizumabA Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Recruiting

Sponsor:

Eli Lilly and Company

Location:

Hialeah FL, Hollywood FL, Fort Myers FL, Tampa FLshow 34 more

Code:

NCT06857942

Conditions

Psoriasis

Overweight or Obesity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tirzepatide